Relief Therapeutics Holding AG (RLF.SW)
CHF 4.1
(-6.82%)
CHF 4.1
(-6.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.03 Million | 6.08 Million | 3.32 Million | - | - | 567 Thousand |
| Cost of Revenue | 16.89 Million | 18.1 Million | 11.9 Million | - | 1000.00 | 55 Thousand |
| Gross Profit | -10.85 Million | -12.02 Million | -8.58 Million | - | -1000.00 | 512 Thousand |
| Operating Expenses | 114.94 Million | 24.52 Million | 26.62 Million | 19.29 Million | 946 Thousand | 788 Thousand |
| Selling, General and Administrative Expenses | 19.42 Million | 10.81 Million | 6.93 Million | 5.49 Million | 915 Thousand | 989 Thousand |
| Research and Development Expenses | 1.32 Million | 12.39 Million | 19.02 Million | 13.64 Million | - | - |
| Other Expenses | 94.36 Million | -1.3 Million | -665 Thousand | -161 Thousand | -31 Thousand | -6000.00 |
| Cost and Expenses | 116.86 Million | 42.62 Million | 38.53 Million | 19.29 Million | 947 Thousand | 843 Thousand |
| Operating Income | -110.82 Million | -36.54 Million | -35.21 Million | -19.29 Million | -947 Thousand | -500 Thousand |
| Interest Expense | 330 Thousand | 196 Thousand | 268 Thousand | 169 Thousand | 138 Thousand | 144 Thousand |
| Income Tax Expense | -13.5 Million | -3.52 Million | -820 Thousand | 1.56 Million | -4.7 Million | 20 Thousand |
| Earnings before Tax | -111.68 Million | -54.31 Million | -35.52 Million | -6.26 Million | -12.16 Million | -416 Thousand |
| Net Income | -98.18 Million | -50.79 Million | -34.7 Million | -7.82 Million | -7.46 Million | -436 Thousand |
| Earnings Per Share Basic | -8.35 | -4.80 | -3.86 | -1.30 | -1.42 | -0.09 |
| Earnings Per Share Diluted | -8.35 | -4.80 | -3.86 | -1.30 | -1.42 | -0.09 |
| Weighted Average Shares Outstanding | 11.75 Million | 10.57 Million | 8.98 Million | 6.03 Million | 5.25 Million | 5.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.75 Million | 10.57 Million | 8.98 Million | 6.03 Million | 5.25 Million | 5.12 Million |
| Gross Margin | -1.80 | -1.98 | -2.59 | - | - | 0.90 |
| EBIT Margin | -17.94 | -5.38 | -9.99 | - | - | -0.85 |
| Profit Margin | -16.27 | -8.35 | -10.45 | - | - | -0.77 |
| EBITDA | -108.2 Million | -50.26 Million | -32.69 Million | -6.09 Million | -946 Thousand | -255 Thousand |
| Earnings Before Tax Margin | -18.37 | -6.01 | -10.60 | - | - | -0.88 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 5.58 Million | 3.01 Million | 6.03 Million | 3.02 Million | 2.83 Million | 6.08 Million |
| Cost of Revenue | 6.48 Million | 8.15 Million | 16.89 Million | 8.74 Million | 9.63 Million | 18.1 Million |
| Gross Profit | -903 Thousand | -5.14 Million | -10.85 Million | -5.71 Million | -6.8 Million | -12.02 Million |
| Operating Expenses | 3.14 Million | 3.11 Million | 9.04 Million | 5.92 Million | 8.77 Million | 24.52 Million |
| Selling, General and Administrative Expenses | 2.41 Million | 2.62 Million | - | 4.9 Million | 6.5 Million | - |
| Research and Development Expenses | 733 Thousand | 395 Thousand | - | 933 Thousand | 1.75 Million | - |
| Other Expenses | - | -94 Thousand | -184 Thousand | -90 Thousand | -517 Thousand | -1.3 Million |
| Cost and Expenses | 9.63 Million | 11.26 Million | 25.93 Million | 14.66 Million | 18.41 Million | 42.62 Million |
| Operating Income | -4.05 Million | -8.25 Million | -19.9 Million | -11.64 Million | -15.57 Million | -36.54 Million |
| Interest Expense | 41 Thousand | 75 Thousand | 330 Thousand | 89 Thousand | 59 Thousand | 196 Thousand |
| Income Tax Expense | 560 Thousand | -5.86 Million | -13.5 Million | -7.64 Million | -1.91 Million | -3.52 Million |
| Earnings before Tax | -3.99 Million | -47.54 Million | -111.68 Million | -64.14 Million | -26.2 Million | -54.31 Million |
| Net Income | -4.55 Million | -41.68 Million | -98.18 Million | -56.49 Million | -24.29 Million | -50.79 Million |
| Earnings Per Share Basic | -0.36 | -3.32 | - | -5.10 | -2.25 | - |
| Earnings Per Share Diluted | -0.36 | -3.32 | - | -5.10 | -2.25 | - |
| Weighted Average Shares Outstanding | 12.54 Million | 12.54 Million | 11.75 Million | 11.08 Million | 10.77 Million | 10.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.54 Million | 12.54 Million | 11.75 Million | 11.08 Million | 10.77 Million | 10.57 Million |
| Gross Margin | -0.16 | -1.71 | -1.80 | -1.89 | -2.40 | -1.98 |
| EBIT Margin | -0.47 | -2.21 | - | -3.29 | -4.84 | - |
| Profit Margin | -0.82 | -13.85 | -16.27 | -18.69 | -8.56 | -8.35 |
| EBITDA | -2.61 Million | -6.64 Million | - | -9.94 Million | -13.75 Million | - |
| Earnings Before Tax Margin | -0.73 | -2.74 | -3.30 | -3.85 | -5.49 | -6.01 |
0127
1269
9950
0QNG
JAGRAN
TDBKF